ASRS
NRIX icon

Arizona State Retirement System’s Nurix Therapeutics NRIX Stock Holding History

Arizona State Retirement System’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Sell
20,883
-1,107
-5% -$18.4K ﹤0.01% 1686
2025
Q4 		$417K Buy
21,990
+1,674
+8% +$24K ﹤0.01% 1578
2025
Q3 		$188K Buy
20,316
+312
+2% +$3.24K ﹤0.01% 1972
2025
Q2 		$228K Buy
20,004
+2,751
+16% +$29.7K ﹤0.01% 1858
2025
Q1 		$205K Buy
17,253
+1,385
+9% +$23.2K ﹤0.01% 1876
2024
Q4 		$299K Buy
15,868
+104
+0.7% +$2.38K ﹤0.01% 1759
2024
Q3 		$354K Buy
15,764
+1,650
+12% +$37.4K ﹤0.01% 1671
2024
Q2 		$295K Buy
+14,114
New +$220K ﹤0.01% 1713
2023
Q4 		– Sell
-10,980
Closed -$86.3K – 2178
2023
Q3 		$86.3K Sell
10,980
-347
-3% -$3.17K ﹤0.01% 2096
2023
Q2 		$113K Buy
11,327
+1,082
+11% +$11K ﹤0.01% 2099
2023
Q1 		$91K Buy
+10,245
New +$107K ﹤0.01% 2130

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Arizona State Retirement System's NRIX Position: Q1 2026 in Review

Arizona State Retirement System reduced its Nurix Therapeutics (NRIX) stake by 5% in Q1 2026, selling an estimated $18.4K and leaving 20,883 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Arizona State Retirement System first reported a position in NRIX in Q1 2023 and has held it in 11 quarters since. The position peaked at $417K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Arizona State Retirement System held 20,883 shares of Nurix Therapeutics worth $324K as of Q1 2026.
  • Arizona State Retirement System sold 1,107 Nurix Therapeutics shares in Q1 2026, an estimated $18.4K.
  • Nurix Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1686 holding.
  • Arizona State Retirement System first reported a position in Nurix Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • Arizona State Retirement System's Nurix Therapeutics position peaked at $417K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.